92 related articles for article (PubMed ID: 16538536)
21. Early breast cancer deaths in women aged 40-74 years diagnosed during the first 5 years of organised mammography service screening in north Sweden.
Bordás P; Jonsson H; Nyström L; Cajander S; Lenner P
Breast; 2004 Aug; 13(4):276-83. PubMed ID: 15325661
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
23. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
[TBL] [Abstract][Full Text] [Related]
24. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
25. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
26. Mammography screening matters for young women with breast carcinoma: evidence of downstaging among 42-49-year-old women with a history of previous mammography screening.
Buseman S; Mouchawar J; Calonge N; Byers T
Cancer; 2003 Jan; 97(2):352-8. PubMed ID: 12518359
[TBL] [Abstract][Full Text] [Related]
27. Cost of breast cancer treatment. A 4-year longitudinal study.
Legorreta AP; Brooks RJ; Leibowitz AN; Solin LJ
Arch Intern Med; 1996 Oct; 156(19):2197-201. PubMed ID: 8885818
[TBL] [Abstract][Full Text] [Related]
28. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
29. Why question screening mammography for women in their forties?
Fletcher SW
Radiol Clin North Am; 1995 Nov; 33(6):1259-71. PubMed ID: 7480669
[TBL] [Abstract][Full Text] [Related]
30. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
31. The costs of treating breast cancer in Australia and the implications for breast cancer screening.
Butler JR; Furnival CM; Hart RF
Aust N Z J Surg; 1995 Jul; 65(7):485-91. PubMed ID: 7611968
[TBL] [Abstract][Full Text] [Related]
32. Mammographic screening and disease presentation of breast cancer patients who die of disease.
Spencer DB; Potter JE; Chung MA; Fulton J; Hebert W; Cady B
Breast J; 2004; 10(4):298-303. PubMed ID: 15239787
[TBL] [Abstract][Full Text] [Related]
33. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
[TBL] [Abstract][Full Text] [Related]
34. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
Ringash J;
CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
36. The value of mammography screening in women under age 50 years.
Eddy DM; Hasselblad V; McGivney W; Hendee W
JAMA; 1988 Mar; 259(10):1512-9. PubMed ID: 3123720
[TBL] [Abstract][Full Text] [Related]
37. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.
Barth RJ; Gibson GR; Carney PA; Mott LA; Becher RD; Poplack SP
AJR Am J Roentgenol; 2005 Jan; 184(1):324-9. PubMed ID: 15615996
[TBL] [Abstract][Full Text] [Related]
38. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
[TBL] [Abstract][Full Text] [Related]
39. Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.
Skrundevskiy AN; Omar OS; Kim J; Soliman AS; Korolchuk TA; Wilson FA
Value Health Reg Issues; 2018 Sep; 16():22-27. PubMed ID: 29626738
[TBL] [Abstract][Full Text] [Related]
40. Estimating the benefits of mammography screening: the impact of study design.
Olsen AH; Njor SH; Lynge E
Epidemiology; 2007 Jul; 18(4):487-92. PubMed ID: 17486020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
